Barbaros Selnur Erdal1, Elliott D Crouser2, Vedat Yildiz3, Mark A King4, Andrew T Patterson4, Michael V Knopp4, Bradley D Clymer5. 1. Department of Electrical and Computer Engineering, The Ohio State University College of Engineering, Columbus, OH; Department of Radiology, The Ohio State University College of Medicine, Columbus, OH. 2. Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, The Ohio State University College of Medicine, Columbus, OH. Electronic address: elliott.crouser@osumc.edu. 3. Center for Biostatistics, The Ohio State University Office of Health Sciences, Columbus, OH. 4. Department of Radiology, The Ohio State University College of Medicine, Columbus, OH. 5. Department of Electrical and Computer Engineering, The Ohio State University College of Engineering, Columbus, OH.
Abstract
BACKGROUND: Chest CT scans are commonly used to clinically assess disease severity in patients presenting with pulmonary sarcoidosis. Despite their ability to reliably detect subtle changes in lung disease, the utility of chest CT scans for guiding therapy is limited by the fact that image interpretation by radiologists is qualitative and highly variable. We sought to create a computerized CT image analysis tool that would provide quantitative and clinically relevant information. METHODS: We established that a two-point correlation analysis approach reduced the background signal attendant to normal lung structures, such as blood vessels, airways, and lymphatics while highlighting diseased tissue. This approach was applied to multiple lung fields to generate an overall lung texture score (LTS) representing the quantity of diseased lung parenchyma. Using deidentified lung CT scan and pulmonary function test (PFT) data from The Ohio State University Medical Center's Information Warehouse, we analyzed 71 consecutive CT scans from patients with sarcoidosis for whom simultaneous matching PFTs were available to determine whether the LTS correlated with standard PFT results. RESULTS: We found a high correlation between LTS and FVC, total lung capacity, and diffusing capacity of the lung for carbon monoxide (P < .0001 for all comparisons). Moreover, LTS was equivalent to PFTs for the detection of active lung disease. The image analysis protocol was conducted quickly (< 1 min per study) on a standard laptop computer connected to a publicly available National Institutes of Health ImageJ toolkit. CONCLUSIONS: The two-point image analysis tool is highly practical and appears to reliably assess lung disease severity. We predict that this tool will be useful for clinical and research applications.
BACKGROUND: Chest CT scans are commonly used to clinically assess disease severity in patients presenting with pulmonary sarcoidosis. Despite their ability to reliably detect subtle changes in lung disease, the utility of chest CT scans for guiding therapy is limited by the fact that image interpretation by radiologists is qualitative and highly variable. We sought to create a computerized CT image analysis tool that would provide quantitative and clinically relevant information. METHODS: We established that a two-point correlation analysis approach reduced the background signal attendant to normal lung structures, such as blood vessels, airways, and lymphatics while highlighting diseased tissue. This approach was applied to multiple lung fields to generate an overall lung texture score (LTS) representing the quantity of diseased lung parenchyma. Using deidentified lung CT scan and pulmonary function test (PFT) data from The Ohio State University Medical Center's Information Warehouse, we analyzed 71 consecutive CT scans from patients with sarcoidosis for whom simultaneous matching PFTs were available to determine whether the LTS correlated with standard PFT results. RESULTS: We found a high correlation between LTS and FVC, total lung capacity, and diffusing capacity of the lung for carbon monoxide (P < .0001 for all comparisons). Moreover, LTS was equivalent to PFTs for the detection of active lung disease. The image analysis protocol was conducted quickly (< 1 min per study) on a standard laptop computer connected to a publicly available National Institutes of Health ImageJ toolkit. CONCLUSIONS: The two-point image analysis tool is highly practical and appears to reliably assess lung disease severity. We predict that this tool will be useful for clinical and research applications.
Authors: Alan C Best; Anne M Lynch; Carmen M Bozic; David Miller; Gary K Grunwald; David A Lynch Journal: Radiology Date: 2003-06-11 Impact factor: 11.105
Authors: Sang Cheol Park; Jun Tan; Xingwei Wang; Dror Lederman; Joseph K Leader; Soo Hyung Kim; Bin Zheng Journal: Phys Med Biol Date: 2011-01-25 Impact factor: 3.609
Authors: Robert P Baughman; Marjolein Drent; Mani Kavuru; Marc A Judson; Ulrich Costabel; Roland du Bois; Carlo Albera; Martin Brutsche; Gerald Davis; James F Donohue; Joachim Müller-Quernheim; Rozsa Schlenker-Herceg; Susan Flavin; Kim Hung Lo; Barry Oemar; Elliot S Barnathan Journal: Am J Respir Crit Care Med Date: 2006-07-13 Impact factor: 21.405
Authors: S B Shaker; A Dirksen; L C Laursen; N Maltbaek; L Christensen; U Sander; N Seersholm; L T Skovgaard; L Nielsen; A Kok-Jensen Journal: Acta Radiol Date: 2004-07 Impact factor: 1.990
Authors: Barbaros S Erdal; Luciano M Prevedello; Songyue Qian; Mutlu Demirer; Kevin Little; John Ryu; Thomas O'Donnell; Richard D White Journal: J Digit Imaging Date: 2018-02 Impact factor: 4.056
Authors: Rik G J Marcellis; Antoine F Lenssen; Geeuwke J de Vries; Robert P Baughman; Chris P van der Grinten; Johny A Verschakelen; Jolanda De Vries; Marjolein Drent Journal: Lung Date: 2012-11-09 Impact factor: 2.584
Authors: Elliott D Crouser; Rachel M Smith; Daniel A Culver; Mark W Julian; Karen Martin; Joanne Baran; Christopher Diaz; Barbaros Selnur Erdal; Erinn M Hade Journal: Chest Date: 2021-05-23 Impact factor: 10.262